Company Filing History:
Years Active: 2011
Title: Jae-Hoon Kim: Innovator in Lateral Flow Assay Technology
Introduction
Jae-Hoon Kim is a notable inventor based in Chuncheon-si, South Korea. He has made significant contributions to the field of diagnostics through his innovative methods and technologies. His work primarily focuses on enhancing the accuracy and efficiency of disease marker detection.
Latest Patents
Jae-Hoon Kim holds a patent for a "Method for the detection of lateral flow assay and strip and laser-induced epifluorescence and compact scanner therefor." This invention discloses a lateral flow quantitative assay method capable of quantitatively determining the concentration and analyzing the spatial distribution of a disease marker. The method employs the principle of laser-induced fluorescence detection, which is based on detecting emitted fluorescence when laser light is focused on the disease marker deposited onto a lateral flow quantitative assay chip. The present invention includes a strip, a laser-induced epifluorescence detection device, and a small scanner for the assay method. This assay method is advantageous for allowing quantitative point-of-care diagnostics in hospitals, specifically detecting disease markers, and enabling accurate quantitative analysis of analytes.
Career Highlights
Throughout his career, Jae-Hoon Kim has worked with various companies, including Bio-Med Photonics, Co., Ltd. and Boditechmed Inc. His experience in these organizations has contributed to his expertise in the field of medical diagnostics and technology development.
Collaborations
Some of his notable coworkers include Kie-Bong Nahm and Eui-Yeol Choi. Their collaborative efforts have further advanced the research and development of innovative diagnostic solutions.
Conclusion
Jae-Hoon Kim's contributions to the field of lateral flow assay technology demonstrate his commitment to improving diagnostic methods. His innovative approaches have the potential to significantly impact point-of-care diagnostics and enhance disease detection capabilities.